<strike id="fvzf9"><input id="fvzf9"><form id="fvzf9"></form></input></strike>
    <strike id="fvzf9"><blockquote id="fvzf9"></blockquote></strike>
  1. 
    
  2. <label id="fvzf9"><optgroup id="fvzf9"></optgroup></label>

    <span id="fvzf9"><input id="fvzf9"></input></span>

  3. 掃碼關(guān)注公眾號           掃碼咨詢(xún)技術(shù)支持           掃碼咨詢(xún)技術(shù)服務(wù)
      
    客服熱線(xiàn):400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  關(guān)于我們  聯(lián)系我們
    4444在线精品免费播放_產(chǎn)品中心-北京博奧森生物技術(shù)有限公司
    首頁(yè) > 產(chǎn)品中心 > 一抗 > 產(chǎn)品信息
    HLA-A Rabbit pAb (bs-2387R)  
    訂購熱線(xiàn):400-901-9800
    訂購郵箱:sales@bioss.com.cn
    訂購QQ:  400-901-9800
    技術(shù)支持:techsupport@bioss.com.cn
    50ul/1180.00元
    100ul/1980.00元
    200ul/2800.00元
    大包裝/詢(xún)價(jià)

    產(chǎn)品編號 bs-2387R
    英文名稱(chēng) HLA-A Rabbit pAb
    中文名稱(chēng) 組織相容性復合體蛋白1抗體
    別    名 Major Histocompatibility Complex, Class I; HLA Class I Histocompatibility Antigen, A alpha Chain; HLAA; HLA Class I Histocompatibility Antigen, A-1 alpha Chain; MHC Class I Antigen HLA-A Heavy Chain; Leukocyte Antigen Class I-A; Human Leukocyte Antigen A; HLAA_HUMAN.  
    Specific References  (1)     |     bs-2387R has been referenced in 1 publications.
    [IF=12.91] Kai Ye. et al. An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen presenting cells in situ. MOL THER. 2022 Jun;:  IHC ;  Mouse.  
    研究領(lǐng)域 腫瘤  細胞生物  免疫學(xué)  信號轉導  轉錄調節因子  細胞分化  
    抗體來(lái)源 Rabbit
    克隆類(lèi)型 Polyclonal
    克 隆 號
    交叉反應 Mouse,Rat (predicted: Human)
    產(chǎn)品應用 IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    理論分子量 40 kDa
    檢測分子量
    細胞定位 細胞膜 
    性    狀 Liquid
    濃    度 1mg/ml
    免 疫 原 KLH conjugated synthetic peptide derived from human HLA-A: 51-150/365 
    亞    型 IgG
    純化方法 affinity purified by Protein A
    緩 沖 液 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
    保存條件 Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
    注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    PubMed PubMed
    產(chǎn)品介紹 HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]

    Function:
    HLA-A (Major Histocompatibility Complex, Class I, A) is a Protein Coding gene. Diseases associated with HLA-A include Severe Cutaneous Adverse Reaction and Birdshot Chorioretinopathy. Among its related pathways are HIV Life Cycle and Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters. Gene Ontology (GO) annotations related to this gene include RNA binding and peptide antigen binding. An important paralog of this gene is HLA-B.

    Subunit:
    Heterodimer of an alpha chain and a beta chain (beta-2-microglobulin). Interacts with human herpesvirus 8 MIR1 protein. Interacts with HTLV-1 p12I accessory protein.

    Subcellular Location:
    Cell Membrane; Type I membrane protein.

    Tissue Specificity:
    Ubiquitous.

    Post-translational modifications:
    Polyubiquitinated in a post ER compartment by interaction with human herpesvirus 8 MIR1 protein. This targets the protein for rapid degradation via the ubiquitin system.

    Similarity:
    Belongs to the MHC class I family.
    highly similar to HLA class I histocompatibility antigen, A-3 alpha chain

    SWISS:
    P04439

    Gene ID:
    3105

    Database links:

    Entrez Gene: 3105 Human

    Omim: 142800 Human

    SwissProt: P04439 Human



    產(chǎn)品圖片
    Tissue/cell: mouse lymphoma tissue; 4% Paraformaldehyde-fixed and paraffin-embedded; Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum,C-0005) at 37℃ for 20 min; Incubation: Anti-MHC class I Polyclonal Antibody, Unconjugated(bs-2387R) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody(SP-0023) and DAB(C-0010) staining
    版權所有 2004-2026 radiasunchina.com 北京博奧森生物技術(shù)有限公司
    通過(guò)國際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書(shū)編號: 00124Q34771R2M/1100
    通過(guò)國際醫療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書(shū)編號: CQC24QY10047R0M/1100
    京ICP備05066980號-1         京公網(wǎng)安備110107000727號
    国产剧情演绎系列丝袜高跟|一级毛片av性爱黄色网站|欧美三级午夜理伦三级|国产av巨作情欲放纵|亚洲 欧美 中文 日韩aⅴ
    <strike id="fvzf9"><input id="fvzf9"><form id="fvzf9"></form></input></strike>
      <strike id="fvzf9"><blockquote id="fvzf9"></blockquote></strike>
    1. 
      
    2. <label id="fvzf9"><optgroup id="fvzf9"></optgroup></label>

      <span id="fvzf9"><input id="fvzf9"></input></span>